Dls Meeting 9.09

1,552 views
1,474 views

Published on

DLS Conference held in Washington, DC September,, 2009

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,552
On SlideShare
0
From Embeds
0
Number of Embeds
12
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Dls Meeting 9.09

  1. 1. A T E A M A P P R O A C H Diabetic Limb Salvage G E O R G E T O W N U N I V E R S I T Y H O S P I TA L 24-26 SEPTEMBER 2009 WASHINGTON,DC Conference Co-Chairmen: Christopher E. Attinger, MD ▲ Richard F. Neville, MD ▲ John S. Steinberg, DPM www.DLSconference.com
  2. 2. ThankYou Photo by Christopher E. Attinger, MD ALPHA KCI ▲ Integra LifeSciences ▲ Georgetown University Hospital/MedStar Health DIAMOND PLATINUM Advanced BioHealing Smith & Nephew GOLD SILVER Merck & Company Gore & Associates ▲ Pamlab Organogenesis Sechrist Industries BRONZE Abbott Vascular Diversified Clinical Lorenz NeuroVasc NormaTec Celleration Services Medical Solutions Perry Baromedical ConvaTec ev3 Medline Industries väsamed Derma Sciences Hollister Wound Care Misonix Wright Medical Technology Integra Foundation Mölnlycke Health Care A T E A M A P P R O A C H Diabetic Limb Salvage G E O R G E T O W N U N I V E R S I T Y H O S P I TA L
  3. 3. T h u r s d ay & F r i d ay 8:30 - 10:30 AM Tours Georgetown University Hospital Center for Wound Healing Bus departs at 8:30 AM from JW Marriott Penn. Ave. Level and returns at 10:30 AM PENNSYLVANIA AVENUE -1 T h u r s d ay 6:00 - 7:45 PM Photo by Christopher E. Attinger, MD Cocktail Reception & Dinner with Exhibitors REGISTRATION/ BALLROOM LEVEL -3 INFORMATION BALLROOM LEVEL -3 WEDNESDAY E XHIBIT H OURS 3:00 PM - 6:00 PM BALLROOM LEVEL -3 THURSDAY THURSDAY 6:00 PM - 7:45 PM 7:00 AM - 7:00 PM FRIDAY FRIDAY 9:30 AM - 4:30 PM 6:00 AM - 6:00 PM SATURDAY Saturday 10:00 AM - 2:00 PM 6:30 AM - 5:30 PM A T E A M A P P R O A C H Diabetic Limb Salvage CONFERENCE MANAGEMENT G E O R G E T O W N U N I V E R S I T Y H O S P I TA L
  4. 4. Thursday 24 September 8:30 – 10:30 AM GEORGETOWN UNIVERSITY HOSPITAL CENTER FOR WOUND HEALING TOUR Bus departs at 8:30 AM from JW Marriott and returns at 10:30 AM. ◆ P ENNSYLVANIA AVENUE -1 This is a non-CME accredited activity. A LL T HURSDAY SESSIONS ARE HELD IN THE G RAND B ALLROOM -3 ADMINISTRATIVE SYMPOSIUM THE BUSINESS OF RUNNING A HOSPITAL-BASED WOUND AND LIMB SALVAGE CENTER: Breaking Down the Barriers and Navigating the Challenges Chair: Linda F. Winger, MSc; Associate Chair: Mark E. Pollard, MHSA 8:00 - 8:15 The National and Financial Impact of Problem Wounds on Our Health System Linda F. Winger, MSc 8:15 - 8:35 Running a Hospital-Based Wound Center: The Financial Tribulations of Dealing with Insurance Providers William J. Ennis, DO, MBA 8:35 - 8:55 Getting the Institution to Buy in: Running and Funding a Wound Care Center in Academic Health David L. Steed, MD 8:55 - 9:15 The CEO’s Perspective: Is the Cost Warranted? Is There More to It? Gary W. Gibbons, MD 9:15 - 9:35 Coding for Success: Correct Coding Leads to Adequate Payment in Wound Care Kathleen D. Schaum, MS 9:35 - 9:55 Cost Effectiveness of Lower Extremity Revascularization: The Impact of Treatment Failure and Reintervention Michael C. Stoner, MD 9:55 - 10:10 Break 10:10 - 10:25 Adding Hyperbaric Oxygen to a Wound Center: The Financial Pros and Cons of Single vs. Multi-Place Chambers Michael Rowley 10:25 - 10:40 Turn-Key Operation Wound Center: The Pluses and Minuses of Contracting with a National Network Reese B. Walter, Jr. 10:40 - 10:55 The Hurdles of Getting a Hospital-Based Wound Care Center Started: Space, Personnel, and Logistics Mark E. Pollard, MHSA 10:55 - 11:10 Compliance, Compliance, Compliance! Following the Rules When Running a Hospital-Based Wound Care Center Helen Turner, RN, CPHQ 11:10 - 11:20 Panel Discussion 11:30 AM – 12:15 PM LUNCH SYMPOSIUM The Role of NPWT in the Team Approach to Limb Salvage: Case Studies Moderators: Christopher E. Attinger, MD; Bauer E. Sumpio, MD, PhD Panel: Peter A. Blume, DPM; Vickie R. Driver, DPM, MS; Francis X. McGuigan, MD; John S. Steinberg, DPM
  5. 5. Thursday 24 September ALL THURSDAY SESSIONS ARE HELD IN THE GRAND BALLROOM -3 THE GLOBAL EPIDEMIC OF DIABETES AND DIABESITY Moderator: John S. Steinberg, DPM 12:30 - 1:00 The Patient’s Perspective of Working and Living with Complications of Diabetes David S. Broder, The Washington Post Columnist 1:00 - 1:25 Public Health Crisis: Diabetes 2009 James R. Gavin, III, MD, PhD 1:25 - 1:50 Do All the National and International Committees, Coalitions, and Associations Really Make a Difference in Limb Salvage Outcomes? Peter Sheehan, MD 1:50 - 2:10 The Sole of the Matter: In Offloading the Diabetic Foot, Is the Gold Standard So Golden? David G. Armstrong, DPM, PhD 2:10 - 2:35 The Epidemiology of Diabetic Foot Ulceration in the United States Gayle E. Reiber, MPH, PhD 2:35 - 3:00 Global Impact of Diabetic Foot Complications Can the World Health Systems Tolerate the Challenge? William Jeffcoate, MD, FRCP 3:00 - 3:45 The Georgetown Team Approach to Diabetic Limb Salvage Christopher E. Attinger, MD; Richard F. Neville, MD; John S. Steinberg, DPM; Mark R. Abbruzzese, MD; Angela M. Calvert, NP; Stephen C. Clement, MD; Paul S.Cooper, MD; Kara S. Couch, NP; David H. Deaton, MD; Katherine J.S. Hubley, RN; Joseph Jones, C.Ped.; Margaret Kugler, NP; Joseph Myers, MD; Amarin Sangkharat, MD 3:45 - 4:00 Refreshment Break OSTEOMYELITIS: SYNONYM FOR AMPUTATION? Moderator: Christopher E. Attinger, MD 4:00 - 4:20 Medical Treatment of Osteomyelitis Can Antibiotics Cure This Diagnosis? William Jeffcoate, MD, FRCP 4:20 - 4:40 Surgical Treatment of Osteomyelitis: Is There More to Do Than Just Cutting It Out? Michael S. Pinzur, MD 4:40 - 5:00 Amputations and Osteomyelitis: HOW to Amputate, When You HAVE to Amputate Robert G. Frykberg, DPM, MPH 5:00 - 5:20 Biofilms, Bioburden, and Senesent Cells: Role of Biofilms in Osteomyelitis and Wound Failure Robert S. Kirsner, MD, PhD 5:20 - 5:40 The Legal Pitfalls of Mismanaged Osteomyelitis Using Evidence-Based Medicine to Protect Yourself and Your Patient Allen M. Jacobs, DPM 5:40 - 6:00 Panel Discussion 6:00 - 7:45 COCKTAIL RECEPTION & DINNER WITH EXHIBITORS CAPITOL BALLROOM & FOYER, GRAND FOYER ◆ BALLROOM LEVEL -3
  6. 6. Friday 25 September 6:30 – 7:30 BREAKFAST SYMPOSIA DIABETIC PERIPHERAL NEUROPATHY: SYMPTOMATIC TREATMENT AND BEYOND Allen M. Jacobs, DPM GRAND BALLROOM -3 ◆ This non-CME accredited activity is supported by Pamlab. OPTIMIZING THE STANDARD OF CARE FOR DIABETIC FOOT ULCERS Robert S. Kirsner, MD, PhD ◆ GRAND BALLROOM, SALON I -3 This non-CME accredited activity is supported by Advanced BioHealing. 7:00 - 8:30 Breakfast ◆ GRAND & CAPITOL FOYERS -3 A LL F RIDAY SESSIONS ARE HELD IN THE G RAND B ALLROOM -3 VASCULAR DISEASE AND THERAPY: CURRENT STATE OF THE ART Moderator: Richard F. Neville, MD 7:50 - 8:00 SVS – APMA Announces Groundbreaking National Collaboration Between Vascular and Podiatric Surgeons Anton N. Sidawy, MD, MPH; Ronald D. Jensen, DPM; George Andros, MD; David G. Armstrong, DPM, PhD; Richard F. Neville, MD 8:00 - 8:20 Diabetic Vascular Disease: What Are the Implications to Today’s Healthcare System Anton N. Sidawy, MD, MPH 8:20 - 8:40 Evolution of Treatment Options for Critical Limb Ischemia Frank J. Veith, MD 8:40 - 9:00 What Have We Learned about Diabetic Vascular Disease? Fact vs. Fiction Gary W. Gibbons, MD 9:00 - 9:30 LIVE CASE Session I: Endovascular Therapy for Peripheral Occlusive Disease Surgeon: David H. Deaton, MD Moderator: Richard F. Neville, MD ◆ Panel: George Andros, MD; Gary W. Gibbons, MD; Bruce H. Gray, DO; William A. Marston, MD; Anton N. Sidawy, MD, MPH 9:30 - 9:50 Challenging Endovascular Cases: What Are the Real Data? Bruce H. Gray, DO 9:50 - 10:05 Challenging Operative Cases: What Are the Real Data? Richard F. Neville, MD 10:05 - 10:35 Break/Exhibits 10:35 -11:00 LIVE CASE Session II: Diabetic Foot Surgery Surgeon: John S. Steinberg, DPM Moderator: Christopher E. Attinger, MD Panel: Vickie R. Driver, DPM, MS; Gary W. Gibbons, MD; Lawrence B. Harkless, DPM 11:00 -11:20 The Reconstructive Surgeon’s View of Endovascular Surgery Lawrence B. Colen, MD 11:20 -11:45 LIVE CASE Session III: Diabetic Foot Surgery Surgeon: John S. Steinberg, DPM Moderator: Christopher E. Attinger, MD Panel: Vickie R. Driver, DPM, MS; Gary W. Gibbons, MD; Lawrence B. Harkless, DPM 12:00 - 1:30 Lunch/Exhibits 12:15 - 1:15 LUNCH SYMPOSIUM Advanced Options for Internal Fixation of the Foot & Ankle Paul S. Cooper, MD; Glenn M. Weinraub, DPM ◆ GRAND BALLROOM -3 This non-CME accredited activity is supported by Integra LifeSciences. 1:15 - 4:00 Internal Fixation Hands-On Workshop Glenn M. Weinraub, DPM ◆ GRAND BALLROOM, SALON I -3 This non-CME accredited activity is supported by Integra LifeSciences.
  7. 7. Friday 25 September 11:45 AM - 12:00 PM GEORGETOWN DISTINGUISHED ACHIEVEMENT AWARD IN DIABETIC LIMB SALVAGE H ONOREE - PETER SHEEHAN, MD Presented by Dr. Richard Goldberg, President, Georgetown University Hospital LOWER EXTREMITY EDEMA: UNDERAPPRECIATED ETIOLOGY FOR NON HEALING? Moderator: John S. Steinberg, DPM 1:30 - 1:55 Edema, Lymphedema, and Problem Wounds: Why Do We Continue to Ignore the Obvious? John M. Macdonald, MD 1:55 - 2:15 LIVE CASE Session IV: Diabetic Limb Salvage Surgeon: Christopher E. Attinger, MD Moderator: John S. Steinberg, DPM Panel: Vickie R. Driver, DPM, MS; Gary W. Gibbons, MD; Lawrence B. Harkless, DPM 2:15 - 2:35 Venous Disease: The Surgeon’s Perspective on Lymphedema, and What Role Do the Veins Play? William A. Marston, MD 2:35 - 3:00 LIVE CASE Session V: External Fixation Surgeon: Paul S. Cooper, MD Moderator: John S. Steinberg, DPM Panel: Michael S. Pinzur, MD; Glenn M. Weinraub, DPM; Dane K. Wukich, MD 3:00 - 3:30 LIVE CASE Session VI: Open Revascularization Surgeon: Richard F. Neville, MD Moderator: Gary W. Gibbons, MD ◆ Panel: George Andros, MD; David H. Deaton, MD; Bruce H. Gray, DO; William A. Marston, MD; Anton N. Sidawy, MD, MPH 3:30 - 4:00 Break/Exhibits 4:00 - 4:30 LIVE CASE Session VII: Diabetic Limb Salvage Surgeon: Christopher E. Attinger, MD Moderator: John S. Steinberg, DPM Panel: Vickie R. Driver, DPM, MS; Gary W. Gibbons, MD; Lawrence B. Harkless, DPM NEUROPATHY: BEGINNING OR END POINT? Moderator: John S. Steinberg, DPM 4:30 - 4:50 Is Offloading Really Enough? Lawrence B. Harkless, DPM 4:50 - 5:10 Surgical Management of Neuropathy: Deciphering Fact from Emotion and Theory Ivica Ducic, MD, PhD 5:10 - 5:30 Defining the Role of Endocrinology in Neuropathy Prevention and Treatment Stephen C. Clement, MD 5:30 - 6:00 Neuropathic Bone Disease: The Effect on Reconstruction Options in the Diabetic Foot Francis X. McGuigan, MD
  8. 8. Saturday 26 September 7:00 - 8:00 BREAKFAST SYMPOSIUM THE ROLE OF DERMAL MATRICES IN LIMB SALVAGE: INTERACTIVE CASE PRESENTATIONS Christopher E. Attinger, MD; William J. Ennis, DO, MBA; Jeffrey E. Janis, MD; Peter Sheehan, MD; John S. Steinberg, DPM ◆ G RAND B ALLROOM -3 6:30 - 8:00 Breakfast ◆ GRAND & CAPITOL FOYERS -3 8:00 AM - 12:30 PM BELOW THE KNEE VASCULAR SYMPOSIUM CURRENT STATE OF THE ART Moderators: Richard F. Neville, MD; Gary W. Gibbons, MD; George Andros, MD GRAND BALLROOM, SALON I -3 8:00 - 8:30 The Future of Interventions: Drug Elution, Stent Design and Characteristics David H. Deaton, MD 8:30 - 9:00 Subintimal Angioplasty: Accidental Success or Temporizing Procedure? George H. Meier, III, MD 9:00 - 9:30 Tibial Artery Stent Angioplasty An Effective Treatment for Critical Ischemia If You Know How to Do It Bruce H. Gray, DO 9:30 - 10:00 Laser Atherectomy: Is It Making a Comeback? Michael C. Stoner, MD 10:00 - 10:30 Revascularization of the Diabetic Foot: The German Experience Prof. Heiner Wenk 10:30 - 11:00 Prosthetic Tibial Bypass: Can We Improve Results with Heparin Bonded Grafts? William D. Jordan, Jr., MD 11:00 - 11:30 Break/Exhibits 11:30 - 12:00 Adjuvant Methods to Accelerate Healing after Revascularization The Vascular Surgeon’s Point of View William A. Marston, MD 12:00 - 12:30 Catheter-Based Atherectomy: Past Experience vs Future Enthusiasm Richard F. Neville, MD
  9. 9. Saturday 26 September 8:00 – 11:00 AM Workshops begin at 8:00, 9:00 and 10:00. HANDS - ON WORKSHOPS Concurrent workshops one hour in duration, repeating three times beginning at 8, 9, and 10. The following workshops are non-CME accredited activities. Principles of Surgical Debridement Physical- and Energy-Based Christopher E. Attinger, MD; Jeffrey E. Janis, MD Wound Healing Modalities RUSSELL & HART ◆ MEETING ROOM LEVEL -2 William J. Ennis, DO, MBA TREASURY ◆ MEETING ROOM LEVEL -2 Outpatient Debridement: The Role of Ultrasound Technologies Compression Techniques Vickie R. Driver, DPM, MS; Matteo Fabbi, MD Laura Jacobs, MD, PhD; Bernardo D. Martinez, MD; RAYBURN ◆ MEETING ROOM LEVEL -2 Paul van Bemmelen, MD, PhD Moderators: Katherine J.S. Hubley, RN; Dressings: Alison Chappell, CRNP Finding Your Way Through the Masses CONGRESSIONAL ◆ LOBBY LEVEL Kara S. Couch, CRNP; Dorothy P. Goodman, RN GRAND BALLROOM, SALON IV ◆ BALLROOM LEVEL -3 Ask the Expert: Complicated Case Review with Offloading: Infectious Disease Specialist Shoes, Orthotics, and Bracing Mark R. Abbruzzese, MD Lawrence B. Harkless, DPM; Joseph Jones, C.Ped. GARDEN TERRACE B ◆ LOBBY LEVEL JUSTICE ◆ MEETING ROOM LEVEL -2 The Basics of Vascular Diagnostics The Role of Prosthetics and Joseph C. Babrowicz, Jr., MD; James Laredo, MD, PhD Amputee Support Groups SENATE ◆ LOBBY LEVEL Charles G. Crone, BS, CP GARDEN TERRACE A ◆ LOBBY LEVEL VAC I: Instructional Course for New Users Peter A. Blume, DPM; Margaret Kugler, NP Bioengineered Alternative Tissues LONGWORTH ◆ MEETING ROOM LEVEL -2 John S. Steinberg, DPM; Marie L. Williams, DPM STATE ◆ MEETING ROOM LEVEL -2 VAC II: Advanced Dressing Applications Karen F. Kim Evans, MD; Nancy R. Megas, NP Bilayered Living Cell Therapy DIRKSEN ◆ MEETING ROOM LEVEL -2 Joseph P. Cavorsi, MD; Brian K. Phillips, CST CANNON ◆ MEETING ROOM LEVEL -2 11:00 - 11:30 Break/Exhibits
  10. 10. S at u r d ay 8:00 - 11:00 AM DLS WORKSHOPS MEETING ROOM LEVEL -2 RUSSELL & HART CANNON RAYBURN JUSTICE DIRKSEN LONGWORTH Surgical Debridement Bilayered Living OP Infectious VAC II VAC I Cell Therapy Debridement Disease TREASURY STATE Wound Bioengineered Healing Alternative Modalities Tissues LOBBY LEVEL CONGRESSIONAL SENATE Compression Vascular Diagnostics BELL STORAGE D R MAIN 14th I ENTRANCE V St. E W A Y STARBUCKS CONCIERGE FRONT DESK GIFT SHOP GARDEN GARDEN TERRACE B TERRACE GARDEN TERRACE Poster A Offloading Abstracts Prosthetics BALLROOM LEVEL -3 GRAND BALLROOM, SALON IV – Dressings
  11. 11. Saturday 26 September T HE FOLLOWING S ATURDAY SESSIONS ARE HELD IN THE G RAND B ALLROOM -3 11:00 - 11:30 Break/Exhibits WOUNDS: INSIDE, OUTSIDE, AND HOW TO HEAL MORE OF THEM Moderator: John S. Steinberg, DPM 11:30 - 11:50 What’s New in Wounds and What Should YOU Be Using Now? Robert S. Kirsner, MD, PhD 11:50 - 12:10 Charcot Foot Wounds: When to Go to the OR vs When to Keep Them in the Clinic Dane K. Wukich, MD 12:10 - 12:30 Anesthesia Risk in Diabetic Limb Salvage: Minimizing Pitfalls, Delays, and Complications Joseph Myers, MD 12:30 - 1:45 Lunch/Exhibits LUNCH SYMPOSIUM 12:30 - 1:30 The Impact of Practicing Evidence-Based Wound Care on Your Practice: Improved Outcomes, Patient Satisfaction, and Business Success Joseph P. Cavorsi, MD This non-CME accredited activity is supported by Organogenesis. WOUNDS: INSIDE, OUTSIDE, AND HOW TO HEAL MORE OF THEM Moderator: Christopher E. Attinger, MD 1:45 - 2:15 Do You REALLY Know about Diabetes? Standards in Saving Lives through Glucose Control Charles A. Reasner, II, MD 2:15 - 2:25 Poster Abstract Award Presentations 2:25 - 3:05 A Patient’s Perspective of the Emotional, Physical, and Compliance CHALLENGES Steven A. Epstein, MD; Andrew Putnam, MD; Julie Andrews; Angela M. Calvert, NP; Katherine J.S. Hubley, RN; Nancy R. Megas, NP; and patient participants 3:05 - 3:25 Diabetic Limb Salvage in a SOCIALIZED Health System: Pros and Cons William Jeffcoate, MD, FRCP 3:25 - 3:45 Hyperbaric Oxygen Therapy: Separating Fact from Fiction and Designing a Protocol for Success Robert A. Warriner, III, MD 3:45 - 4:05 Innovative Biotechnology and Wound Healing: Can We Afford It? William J. Ennis, DO, MBA 4:05 - 5:00 Problem Cases: Rapid Fire Presentations from the Experts Vickie R. Driver, DPM, MS; William J. Ennis, DO, MBA; Robert G. Frykberg, DPM, MPH; Lawrence B. Harkless, DPM; Jeffrey E. Janis, MD; Michael S. Pinzur, MD; Dane K. Wukich, MD 5:00 - 5:10 Panel Discussion Christopher E. Attinger, MD; Richard F. Neville, MD; John S. Steinberg, DPM
  12. 12. A C C R E D I TAT I O N Accreditation Statement: The Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Georgetown University Hospital designates this educational activity for a maximum of 25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. International Conference Management, Inc., is approved by the Council on Podiatric Medical Education as a sponsor of continuing medical education in podiatric medicine. International Conference Management, Inc. has approved this conference for a maximum of 25 continuing medical education contact hours of CPME credit. Georgetown University Hospital Department of Nursing Education is an approved provider of continuing nursing education by the Maryland Nurses Association, an accredited provider by the American Nurses Credentialing Center's Commission on accreditation. Nurses will be awarded a maximum of 25 contact hours for successfully completing the program. Disclosure of Financial Relationships with Any Commercial Interest As sponsors accredited by the ACCME and CPME, it is the policy of Georgetown University Hospital and International Conference Management, Inc., to require that everyone who is in the position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity. The ACCME and CPME consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. Faculty and planners who refuse to disclose relevant financial relationships will be disqualified from participating in the CME activity. For an individual with no relevant financial relationship(s), the participant must be informed that no conflicts of interest or financial relationship(s) exist. Conference Objectives: This course will enhance the background, knowledge and skills of attendees in the science of diabetic limb salvage. At the conclusion of this CME activity, participants should be able to: discuss the public health crisis of diabetic limb loss ▲ discuss the pain of sensory loss and non-compliance ▲ discuss the options in vascular interventional technology and techniques, both surgical and endovascular ▲ discuss the complexities of biomechanics, limb salvage, the problem wound, wound based infection, preserving limb length ▲ cite the financial and social impact of diabetic limb salvage and amputation ▲ integrate into their practices the knowledge obtained through the didactic lectures, workshops and live surgical cases. Target Audience: This program has been planned, designed, and is intended for Diabetes & Wound Healing Specialists ▲ Vascular Surgeons ▲ Orthopaedic Surgeons ▲ Podiatric Surgeons ▲ Plastic Surgeons ▲ Endocrinologists ▲ PCPs ▲ Infectious Disease Specialists ▲ Cardiovascular & Endovascular Specialists ▲ NPs ▲ PTs ▲ RNs ▲ CDEs ▲ Peripheral Nerve Specialists ▲ the entire team who work on the diabetic foot and limb salvage Course Description: Georgetown University Hospital's Team Approach to Diabetic Limb Salvage conference is intended to better equip each member of the health care team with the education and resources needed to heal wounds and prevent amputations. It features a prominent multidisciplinary faculty that promotes the importance of every member of the team. The course is designed for health care practitioners of all specialties and promotes an evidence-based approach. The meeting format will include didactic lectures, hands-on workshops, specialty symposia, and live surgical case demonstrations for the purpose of providing a live interactive learning experience. Acknowledgment: This continuing medical education activity is supported by unrestricted educational grants from contributing organizations. A complete list is published in this program notebook. Advisory: Certificates of Attendance for CMEs and Contact hours are available for you to print online during and after this conference. Attendees can update or edit their Attendance Checklist or CME Certificate through October 15, 2009. After that time, no further changes can be made in the forms. Certificates can be printed for a period of two years.
  13. 13. HOW TO PRINT YOUR CME CERTIFICATE Please print your own Diabetic Limb Salvage CME certificate. It’s easy! You can do it at the conference, or later at your home or office. 1. Logon to the DLS CME site. AT THE DLS CONFERENCE: Go to the Information Desk on -3 Level. Using one of the computers, enter your LAST NAME as your User Name. Then enter your Password, which is the ID NUMBER printed on your conference name badge. AT HOME/OFFICE: Immediately after the conference, you will receive an email with a personalized link to the CME site. Click on the link or paste it into your browser. 2. Open the Attendance Checklist. Then click on the box beside each education session you attended. The Attendance Checklist form will automatically total your CME/Contact hours, up to a maximum of 25 hours. Click the submit button when done. Note: You can update or edit your Attendance Checklist through October 15, 2009. After that time, no further changes can be made in the form. 3. Open the CME Certificate and print it. Note: You can print your certificate as many times as you like for a period of two years.
  14. 14. Faculty G E O R G E T O W N U N I V E R S I T Y H O S P I TA L C ONFERENCE C O -C HAIRMEN Christopher E. Attinger, MD ▲ Richard F. Neville, MD ▲ John S. Steinberg, DPM C ONFERENCE C OMMITTEE Mark R. Abbruzzese, MD Charles G. Crone, BS, CP Anton N. Sidawy, MD, MPH David G. Armstrong, DPM, PhD David H. Deaton, MD Gail E. Thurkauf, RN, MS Stephen C. Clement, MD Ivica Ducic, MD, PhD Helen Turner, RN, CPHQ Paul S. Cooper, MD William J. Ennis, DO, MBA Dennis A. Vitrella, MA Kara S. Couch, CRNP Mark E. Pollard, MHSA Linda F. Winger, MSc DLS 2009 FACULTY George Andros, MD Karen F. Kim Evans, MD Joseph Jones, C.Ped. Valley Presbyterian Hospital Veterans Affairs Medical Center Nascott Orthotics and Prosthetics Los Angeles Vascular Specialists Washington, DC Fairfax, VA Los Angeles, CA Robert G. Frykberg, DPM, MPH William D. Jordan, Jr., MD David G. Armstrong, DPM, PhD Carl T. Hayden VA Medical Center University of Alabama at Birmingham University of Arizona College of Medicine Phoenix, AZ Birmingham, AL Tucson, AZ Robert S. Kirsner, MD, PhD Peter A. Blume, DPM James R. Gavin, III, MD, PhD University of Miami Yale University Emory University School of Medicine Miller School of Medicine New Haven, CT Fairburn, GA Miami, FL Gary W. Gibbons, MD John M. Macdonald, MD David S. Broder Boston University School of Medicine University of Miami The Washington Post Quincy Medical Center Miller School of Medicine Washington, DC Boston, MA Miami, FL Lawrence B. Colen, MD William A. Marston, MD Norfolk Plastic Surgery Bruce H. Gray, DO University of North Carolina Norfolk, VA Institute of Vascular Health Chapel Hill, NC Greenville, SC Kara S. Couch, CRNP George H. Meier, III, MD Walter Reed Army Medical Center Lawrence B. Harkless, DPM University of Cincinnati Washington, DC Western University of Health Sciences Cincinnati, OH Charles G. Crone, BS, CP Pomona, CA Michael S. Pinzur, MD Nascott Rehabilitation Services Loyola University Medical Center Fairfax, VA Allen M. Jacobs, DPM Chicago, IL Dr. Allen M. Jacobs & Associates Vickie R. Driver, DPM, MS St. Louis, MO Charles A. Reasner, II, MD Boston University School of Medicine University of Texas Health Science Center Boston Medical Center Jeffrey E. Janis, MD San Antonio, TX Boston, MA University of Texas Southwestern Medical Center Gayle E. Reiber, MPH, PhD William J. Ennis, DO, MBA Dallas, TX University of Washington University of Illinois at Chicago Seattle, WA St. James Center for Comprehensive William Jeffcoate, MD, FRCP Michael Rowley Wound & Disease Management Nottingham City Hospital Diversified Clinical Services Chicago, IL Nottingham, UK Jacksonville, FL
  15. 15. Faculty continued Kathleen D. Schaum, MS Michael C. Stoner, MD Robert A. Warriner, III, MD Kathleen D. Schaum & Associates East Carolina University Diversified Clinical Services Lake Worth, FL Greenville, NC The Woodlands, TX Glenn M. Weinraub, DPM Peter Sheehan, MD Bauer E. Sumpio, MD, PhD Kaiser Permanente Medical Group Sheehan Health Management Yale University School of Medicine Fremont, CA New York, NY New Haven, CT Prof. Heiner Wenk Anton N. Sidawy, MD, MPH Frank J. Veith, MD Klinikum Bremen Nord Veterans Affairs Medical Center New York University Bremen, Germany Washington, DC New York, NY Dane K. Wukich, MD David L. Steed, MD Reese B. Walter, Jr. University of Pittsburgh Medical Center University of Pittsburgh Diversified Clinical Services Comprehensive Foot and Ankle Center Pittsburgh, PA Raleigh, NC Pittsburgh, PA G EORGETOWN U NIVERSITY H OSPITAL FACULTY Mark R. Abbruzzese, MD Ivica Ducic, MD, PhD Richard F. Neville, MD Julie Andrews Steven A. Epstein, MD Brian K. Phillips, CST Christopher E. Attinger, MD Dorothy P. Goodman, RN Mark E. Pollard, MHSA Joseph C. Babrowicz, Jr., MD Katherine J. S. Hubley, RN Andrew Putnam, MD Angela M. Calvert, NP Margaret Kugler, NP Amarin Sangkharat, MD Alison Chappell, CRNP James Laredo, MD, PhD John S. Steinberg, DPM Stephen C. Clement, MD Francis X. McGuigan, MD Helen Turner, RN, CPHQ Paul S. Cooper, MD Nancy R. Megas, NP Linda F. Winger, MSc David H. Deaton, MD Joseph Myers, MD PETER SHEEHAN, MD 2009 G EORGETOWN D ISTINGUISHED A CHIEVEMENT AWARD IN D IABETIC L IMB S ALVAGE D r. Peter Sheehan is an internationally known and respected diabetes researcher and educator, unique in his ability to bring all disciplines to bear on diabetic limb salvage and to raise awareness about the impact of diabetes on patients and on our health systems. He has been called an ambassador to a world audience on diabetes and peripheral vascular disease and a thought leader in multidisciplinary limb salvage. Formerly director of the Diabetes Foot and Ankle Center at New York University Medical Center's Hospital for Joint Diseases Orthopaedic Institute and a senior faculty member at the Mount Sinai School of Medicine in New York City, Dr. Sheehan is president of Sheehan Health Management, consulting with medical institutions and with technology and biotechnology companies. Dr. Sheehan has been actively involved in numerous clinical trials dealing with wound healing, diabetic neuropathy and peripheral arterial disease. He has worked on both the local and national level with the American Diabetes Association and maintains an active role with the PAD Coalition. A member of multiple editorial boards, Dr. Sheehan also is the author of many peer-reviewed articles and book chapters. He is program chair of the annual Wound Healing: Science and Industry meeting, now in its 10th year. Dr. Sheehan is a graduate of the SUNY-Downstate School of Medicine, where he also completed his residency in internal medicine. He continued his training at Yale University School of Medicine in New Haven where he completed a fellowship in endocrinology and metabolism. PAST AWARD RECIPIENTS: Lawrence B. Harkless, DPM, 2008; David G. Armstrong, DPM, PhD, 2007.
  16. 16. Faculty Disclosures It is the policy of Georgetown University Hospital and International Conference Management, Inc. (ICM) to insure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any Georgetown University Hospital or ICM sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented. A complete updated list is available at the faculty counter next to registration. Name Commercial Interest Nature of Financial Relationship Mark R. Abbruzzese, MD Cubicin Research Schering-Plough Speaking and Teaching Julie Andrews No relevant financial relationships with any commercial interests to disclose. George Andros, MD No disclosure submitted at press time. David G. Armstrong, DPM, PhD No relevant financial relationships with any commercial interests to disclose. Christopher E. Attinger, MD No disclosure submitted at press time. Joseph C. Babrowicz, Jr., MD No relevant financial relationships with any commercial interests to disclose. Peter A. Blume, DPM KCI Consultant David S. Broder No disclosure submitted at press time. Angela M. Calvert, CRNP No relevant financial relationships with any commercial interests to disclose Alison Chappell, CRNP No relevant financial relationships with any commercial interests to disclose Stephen C. Clement, MD No relevant financial relationships with any commercial interests to disclose Lawrence B. Colen, MD No relevant financial relationships with any commercial interests to disclose. Paul S. Cooper, MD No disclosure submitted at press time. Kara S. Couch, CRNP Organogenesis, Eagle Health Care Honoraria Charles G. Crone, BS, CP No relevant financial relationships with any commercial interests to disclose. David H. Deaton, MD Aptus Endosystems Chief Medical Consultant ROX Medical, M2S Consultant Boston Scientific Clinical Investigator Vickie R. Driver, DPM, MS No disclosure submitted at press time. Ivica Ducic, MD, PhD No relevant financial relationships with any commercial interests to disclose. William J. Ennis, DO, MBA No disclosure submitted at press time. Steven A. Epstein, MD No relevant financial relationships with any commercial interests to disclose. Robert G. Frykberg, DPM, MPH SBi, KCI Speaker Regenesis Biomedical Advisory Board Advanced BioHealing Speaker/Research/Advisory Board James R. Gavin, III, MD, PhD No disclosure submitted at press time. Gary W. Gibbons, MD No disclosure submitted at press time. Dorothy P. Goodman, RN No relevant financial relationships with any commercial interests to disclose. Bruce H. Gray, DO No relevant financial relationships with any commercial interests to disclose Lawrence B. Harkless, DPM Organogenesis, Sanofi Aventis Speaker Bureau Katherine J.S. Hubley, RN No relevant financial relationships with any commercial interests to disclose. Allen M. Jacobs, DPM No disclosure submitted at press time. Jeffrey E. Janis, MD Ethicon, Mentor, Integra LifeSciences Advisory Council LifeCell Speaker’s Bureau
  17. 17. Name Commercial Interest Nature of Financial Relationship William Jeffcoate, MD, FRCP No relevant financial relationships with any commercial interests to disclose Joseph Jones, C.Ped. No relevant financial relationships with any commercial interests to disclose. William D. Jordan, Jr., MD W.L. Gore Investigator, Consultant Karen F. Kim Evans, MD No disclosure submitted at press time. Robert S. Kirsner, MD, PhD No disclosure submitted at press time. Margaret Kugler, ACNP No relevant financial relationships with any commercial interests to disclose. James Laredo, MD, PhD No disclosure submitted at press time. John M. Macdonald, MD 3M Speaker, Consultant William A. Marston, MD Advanced BioHealing, Healthpoint Consultant, Research Diversified Clinical Services Advisory Board Francis X. McGuigan, MD No disclosure submitted at press time. Nancy R. Megas, CRNP No relevant financial relationships with any commercial interests to disclose. George H. Meier, III, MD No relevant financial relationships with any commercial interests to disclose. Joseph Myers, MD No disclosure submitted at press time. Richard F. Neville, MD No disclosure submitted at press time. Brian K. Phillips, CST No relevant financial relationships with any commercial interests to disclose. Michael S. Pinzur, MD Small Bone Innovations, Smith & Nephew Consulting Biomimmetics Research funding Ascension Orthopaedics Lecture Mark E. Pollard, MHSA No relevant financial relationships with any commercial interests to disclose. Andrew T. Putnam, MD Wyeth Pharmaceuticals Speaker’s Bureau Charles A. Reasner, II, MD Takeda, Novo Nordisk, Amylin/Lilly Speaker’s Bureau Gayle E. Reiber, MPH, PhD No relevant financial relationships with any commercial interests to disclose. Michael Rowley Diversified Clinical Services Employee and Officer Amarin Sangkharat, MD No relevant financial relationships with any commercial interests to disclose. Kathleen D. Schaum, MS Healthpoint Employee Peter Sheehan, MD No disclosure submitted at press time. Anton N. Sidawy, MD, MPH No disclosure submitted at press time. David L. Steed, MD Stemnion Employee John S. Steinberg, DPM Smith & Nephew, KCI, ArthroCare, Integra, Organogenesis Consultant Michael C. Stoner, MD W. L. Gore Consultant, Research Bauer Sumpio, MD No disclosure submitted at press time. Helen Turner, RN, CPHQ No disclosure submitted at press time. Frank J. Veith, MD Vascular Innovation Major Stockholder Reese B. Walter, Jr. No relevant financial relationships with any commercial interests to disclose. Robert A. Warriner, III, MD Diversified Clinical Services Chief Medical Officer Glenn M. Weinraub, DPM No relevant financial relationships with any commercial interests to disclose. Heiner Wenk No relevant financial relationships with any commercial interests to disclose. Linda F. Winger, MSc No disclosure submitted at press time. Dane K. Wukich, MD Arthrex Consultant
  18. 18. COMMERCIAL FUNDING & Funding for the conference has been provided by educational grants or exhibit funding from the following companies 3M Diversified Clinical Services Abbott Vascular DJO ACI Medical Edwards Lifesciences Advanced BioHealing Elsevier/Saunders ARANZ Medical ev3 Arobella Medical Foot Solutions ArthroCare Sports Medicine Georgetown University Hospital MedStar Health Bianco Brothers Instruments Gore & Associates Bio Compression Systems Hollister Wound Care BioMedix Vascular Solutions HS Pharmaceuticals Brican Systems Hyperbaric America Calmoseptine Innovative Therapies Care-Tech Laboratories Integra Foundation Celleration Integra LifeSciences ConvaTec Kalypto Medical Depuy Orthopaedics KCI Derma Sciences Koven Technology
  19. 19. FINANCIAL SUPPORTERS Funding for the conference has been provided by educational grants or exhibit funding from the following companies Lorenz NeuroVasc SciVolutions MedEfficiency Sechrist Industries Medical Solutions Shoe Care Innovations Medline Industries Small Bone Innovations Merck & Company Smith & Nephew Milliken & Company Soluble Systems Misonix Spectranetics Mölnlycke Health Care Tekscan Monarch Labs ULURU Nascott Orthotics & Prosthetics väsamed NormaTec Vasyli Medical novel Volcano Corporation Ocean Aid Vomaris Innovations Organogenesis Osborn Medical Wound Care Innovations Ossur Americas Wound Care Technologies Pamlab Wright Medical Technology Perry Baromedical Xenna Corporation PuriCore Zymogenetics
  20. 20. Evaluations Please complete evaluations online or on computers in the information area throughout the conference. Onsite Computers Supported by KCI DPM Sign In Required daily in the main education ballroom View Poster Abstracts GARDEN TERRACE ◆ LOBBY LEVEL Poster Abstract Area and Online Viewing Supported by KCI
  21. 21. O NLINE S TREAMING VIDEO of the DLS E DUCATIONAL P ROGRAM will be available at www.DLSconference.com Funding for DLS Streaming Video graciously provided by Merck & Company and Integra LifeSciences.
  22. 22. DLS C ONFERENCE 2009 E XHIBITOR F LOORPLAN BALLROOM LEVEL -3 PLASMA PLASMA Organogenesis väsamed Gore & Abbott 4 25 Derma 22 15 Associates 14 7 Medline Vascular Sciences Industries SciVolutions Shoe Care Vomaris Spectranetics G U H Diversified Medical 69 26 Merck Clinical 21 16 Pamlab Sechrist 13 8 Perry Solutions 3 Services Industries Baromedical 68 27 Hollister 9 Celleration ConvaTec 2 Wound Care 19 17 Integra KCI 11 Lorenz 67 Advanced LifeSciences ev3 1 28 10 NeuroVasc BioHealing Innovations Smith & Nephew 66 CAPITOL BALLROOM 65 49 50 51 52 MedEfficiency Monarch ULURU Ossur Bio Labs Calmoseptine Compressions 42 43 44 ACI GRAND BALLROOM - EDUCATION Zymogenetics Volcano DePuy Medical 53 54 55 45 Arobella 56 Elsevier Mölnlycke 41 Saunders 33 60 59 58 57 46 DJO novel Koven Nascott NormaTec 40 ArthroCare Foot Solutions 39 3M HS Care-Tech WCI Pharma SBi 61 62 63 64 47 Brican Systems 31 PuriCore 38 Wound Care 48 Technologies Vasyli Medical 76 32 30 ARANZ 35 34 74 70 71 Soluble Kalypto Systems Medical 37 Tekscan Innovative Ocean Hyperbaric Milliken Xenna Therapies Aid America PLASMA 36 BioMedix Edwards Lifesciences Misonix Wright Medical 72 REGISTRATION ALCOVE 1 ALCOVE 2 WC INFORMATION
  23. 23. DLS E XHIBITOR L EGEND 3M ................................................................................39 Medical Solutions ............................................................3 Abbott Vascular ..............................................................4 Medline Industries ..........................................................7 ACI Medical ..................................................................55 Merck & Company ........................................................26 Advanced BioHealing ................................................ 28 Milliken & Company ......................................................70 ARANZ Medical ..........................................................30 Misonix ................................................................Alcove 1 Arobella Medical ..........................................................45 Mölnlycke Health Care..................................................56 ArthroCare Sports Medicine ...................................... 40 Monarch Labs ..............................................................50 Bio Compression Systems ..........................................44 Nascott Orthotics & Prosthetics ....................................58 BioMedix Vascular Solutions ...................................... 36 NormaTec......................................................................57 Brican Systems ............................................................47 novel ............................................................................60 Calmoseptine ................................................................42 Ocean Aid ....................................................................34 Care-Tech Laboratories ................................................61 Osborn Medical ............................................................73 Celleration ......................................................................9 Organogenesis..............................................................15 ConvaTec ........................................................................2 Ossur Americas ............................................................52 Depuy Orthopaedics ....................................................54 Pamlab ..........................................................................16 Derma Sciences............................................................22 Perry Baromedical ..........................................................8 Diversified Clinical Services..........................................21 PuriCore ........................................................................31 DJO ..............................................................................46 SciVolutions ..................................................................65 Edwards Lifesciences ..................................................72 Sechrist Industries ........................................................13 Elsevier/Saunders ........................................................41 Shoe Care Innovations ................................................66 ev3 ..................................................................................1 Small Bone Innovations ................................................64 Foot Solutions ..............................................................33 Smith & Nephew ..........................................................19 Georgetown University Hospital/ MedStar Health, Soluble Systems ..........................................................76 Nurse Recruitment ....................................................69 Spectranetics ................................................................68 Gore & Associates ........................................................14 Tekscan ........................................................................37 Hollister Wound Care ....................................................27 ULURU..........................................................................51 HS Pharmaceuticals......................................................63 väsamed........................................................................25 Hyperbaric America ......................................................74 Vasyli Medical ..............................................................48 Innovative Therapies ....................................................35 Volcano Corporation ....................................................53 Integra LifeSciences ....................................................17 Vomaris Innovations......................................................67 Kalypto Medical ............................................................32 Wound Care Innovations ..............................................62 KCI ................................................................................11 Wound Care Technologies ............................................38 Koven Technology ........................................................59 Wright Medical Technology ................................Alcove 2 Lorenz NeuroVasc ........................................................10 Xenna Corporation ........................................................71 MedEfficiency ................................................................49 Zymogenetics................................................................43
  24. 24. September 2009 April 2010 A T E A M A P P R O A C H S M T W T F S S M T W T F S Diabetic Limb Salvage 1 2 3 4 5 1 2 3 G E O R G E T O W N U N I V E R S I T Y H O S P I TA L 6 7 8 9 10 11 12 4 5 6 7 8 9 10 13 14 15 16 17 18 19 11 12 13 14 15 16 17 20 21 22 27 28 29 23 30 24 25 26 18 19 20 21 22 25 26 27 28 29 23 30 24 F U T U R E D AT E S October 2009 May 2010 14-16 OCTOBER 2010 S M T W T 1 F 2 S 3 S M T W T F S 1 15 - 17 SEPTEMBER 2011 4 5 6 7 8 9 10 2 3 4 5 6 7 8 11 12 13 14 15 16 17 9 10 11 12 13 14 15 JW MARRIOTT PENNSYLVANIA AVENUE 18 19 20 21 22 23 24 16 17 18 19 20 21 22 25 26 27 28 29 30 31 23 30 24 31 25 26 27 28 29 WA S H I N G T O N , D C November 2009 June 2010 S M T W T F S S M T W T F S 1 2 3 4 5 6 7 1 2 3 4 5 8 9 10 11 12 13 14 6 7 8 9 10 11 12 15 16 17 18 19 20 21 13 14 15 16 17 18 19 22 23 24 25 26 27 28 20 21 22 23 24 25 26 29 30 27 28 29 30 December 2009 July 2010 S M T W T F S S M T W T F S 1 2 3 4 5 1 2 3 6 7 8 9 10 11 12 4 5 6 7 8 9 10 13 14 15 16 17 18 19 11 12 13 14 15 16 17 20 21 22 23 24 25 26 18 19 20 21 22 23 24 27 28 29 30 31 25 26 27 28 29 30 31 January 2010 August 2010 S M T W T F S S M T W T F S 1 2 1 2 3 4 5 6 7 3 4 5 6 7 8 9 8 9 10 11 12 13 14 10 11 12 13 14 15 16 15 16 17 18 19 20 21 17 18 19 20 21 22 23 22 23 24 25 26 27 28 24 25 26 27 28 29 30 29 30 31 31 February 2010 September 2010 S M T W T F S S M T W T F S 1 2 3 4 5 6 1 2 3 4 7 8 9 10 11 12 13 5 6 7 8 9 10 11 14 15 16 17 18 19 20 12 13 14 15 16 17 18 21 22 23 24 25 26 27 19 20 21 22 23 24 25 28 26 27 28 29 30 March 2010 October 2010 S M T W T F S S M T W T F S 1 2 3 4 5 6 1 2 7 8 9 10 11 12 13 3 4 5 6 7 8 9 14 15 16 17 18 19 20 10 11 12 13 14 15 16 21 22 23 24 25 26 27 17 18 19 20 21 22 23 28 29 30 31 24 25 26 27 28 29 30 31
  25. 25. A T E A M Diabetic Limb Salvage A P P R O A C H G E O R G E T O W N U N I V E R S I T Y H O S P I TA L Hold the Date WA S H I N G T O N , D C ▲ J W M A R R I O T T P E N N AV E 14-16 OCTOBER 2010 Photo by Christopher E. Attinger, MD Conference Co-Chairmen: C h r i s t o p h e r E . A t t i n g e r , M D ▲ R i c h a r d F. N e v i l l e , M D ▲ John S. Steinberg, DPM
  26. 26. Georgetown University Hospital Washington, DC The next generation of wound care is already here. At Georgetown University Hospital, one of the nation’s most respected academic healthcare delivery networks, we’re aggressively implementing the most advanced therapeutics and technologies to meet the phenomenal rise in demand for wound care. Our soon-to-be-delivered hyperbaric oxygen chambers are just one example of our leading-edge treatment of chronic and complex wounds. Let’s talk about your options with one of the nation’s top nursing teams: the Magnet® nurses of Georgetown. See Us At Our Booth Relocation assistance is available. Call Eileen Ferrell, RN, MS at (877) 486- 9676, apply online or send your resume to Georgetown University Hospital, Attn: Eileen Ferrell, RN, MS, 3800 Reservoir Rd., NW, Washington, DC 20007, fax: (202) 444-4080, e-mail: FERRELEB@gunet.georgetown.edu. AA/EOE. www.TheNursesHospital.com

×